[artículo] 
inJournal of Clinical Psychopharmacology > Año 2005 - Vol. 25 - No. 6 (Diciembre) . - pp. 527-532

Título :	Dose-dependent interaction of paroxetine with risperidone in schizophrenic patients
Tipo de documento:	texto impreso
Autores:	Manabu Saito, Autor ; Norio Yasui Furukori, Autor ; Taku Nakagami, Autor
Fecha de publicación:	2023
Artículo en la página:	pp. 527-532
Idioma :	Inglés (eng) Idioma original : Inglés (eng)
Palabras clave:	Antidepresivos, Antipsicóticos, Interacciones medicamentosas, Isoxazoles, Palmitato de paliperidona, Paroxetina, Risperidona, Esquizofrenia.
Resumen:	Augmentation with paroxetine (10-40 mg/d) for antipsychotic treatment may improve the negative symptoms in schizophrenic patients but involves a risk of drug-drug interaction. We studied the effects of paroxetine on plasma concentrations of risperidone and 9-hydroxyrisperidone and their clinical symptoms in risperidone-treated patients.
Link:	./index.php?lvl=notice_display&id=30876

[artículo] Dose-dependent interaction of paroxetine with risperidone in schizophrenic patients [texto impreso] / Manabu Saito, Autor ; Norio Yasui Furukori, Autor ; Taku Nakagami, Autor . - 2023 . - pp. 527-532.
Idioma : Inglés (eng) Idioma original : Inglés (eng)
in Journal of Clinical Psychopharmacology > Año 2005 - Vol. 25 - No. 6 (Diciembre) . - pp. 527-532

Palabras clave:	Antidepresivos, Antipsicóticos, Interacciones medicamentosas, Isoxazoles, Palmitato de paliperidona, Paroxetina, Risperidona, Esquizofrenia.
Resumen:	Augmentation with paroxetine (10-40 mg/d) for antipsychotic treatment may improve the negative symptoms in schizophrenic patients but involves a risk of drug-drug interaction. We studied the effects of paroxetine on plasma concentrations of risperidone and 9-hydroxyrisperidone and their clinical symptoms in risperidone-treated patients.
Link:	./index.php?lvl=notice_display&id=30876